Once a target has been prioritised from a biological evidence perspective, researchers may wish to perform a series of experiments to validate the biological role in the cancer of interest, and potentially explore whether the target could be progressed in drug discovery. Now, through the enhanced functionality and integration of data in canSAR, we are able to identify and provide key information to inform experimental design for mechanistic evaluation and target validation.
